Work Area: Litigation

Latest content

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

Ten things to know about patent litigation in the Central District of California

Docket Navigator data shows the nation’s fourth-busiest patent venue is less defendant-friendly than its neighbour to the north

17 January 2022

Without injunctions, the US patent system is rigged in favour of deep pocket defendants

Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions

14 January 2022

Skinny label concerns persist for generics, despite good news from Delaware

A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs

14 January 2022

Landmark Dusseldorf non-FRAND finding is big news for joint licensing programmes

SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling

13 January 2022

VLSI claims “gamesmanship” in IPR attack on patent from $2 billion Intel verdict

Shell company’s validity challenge threatens the eye-watering damages award and Fortress-backed entity says it could open the door to abuse of the PTAB system

12 January 2022

New wave of fitness-related patent litigation driven by booming market and brand concerns

Recent lawsuits involving Nike, Peloton, lululemon and others suggest an explosion in consumer demand for high-tech workout gear is leading to IP conflict

11 January 2022

Why the Illinois Northern District has become a hotbed of design patent injunctions

Lead counsel representing brands Oakley and Ugg explains how design rights help companies pursue copycats that have gotten savvier about trademark use

10 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

Landmark Dutch appeal court decision reduces risk of third-party damages against pharma patentees

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

Unlock unlimited access to all IAM content